
Arpad Fabian-kovacs
Examiner (ID: 16444)
Most Active Art Unit | 3671 |
Art Unit(s) | 3616, 3671 |
Total Applications | 3046 |
Issued Applications | 2528 |
Pending Applications | 99 |
Abandoned Applications | 392 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5315568
[patent_doc_number] => 20090280166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'FERRITIN AS A THERAPEUTIC TARGET IN ABNORMAL CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/422709
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 28908
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280166.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422709 | FERRITIN AS A THERAPEUTIC TARGET IN ABNORMAL CELLS | Apr 12, 2009 | Abandoned |
Array
(
[id] => 5495421
[patent_doc_number] => 20090263449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'DELIVERY OF NUCLEIC ACID COMPLEXES FROM MATERIALS INCLUDING NEGATIVELY CHARGED GROUPS'
[patent_app_type] => utility
[patent_app_number] => 12/421285
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11246
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263449.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421285
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421285 | DELIVERY OF NUCLEIC ACID COMPLEXES FROM MATERIALS INCLUDING NEGATIVELY CHARGED GROUPS | Apr 8, 2009 | Abandoned |
Array
(
[id] => 5385178
[patent_doc_number] => 20090226423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Protein kinase C as a target for the treatment of respiratory syncytial virus'
[patent_app_type] => utility
[patent_app_number] => 12/384384
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15189
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226423.pdf
[firstpage_image] =>[orig_patent_app_number] => 12384384
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/384384 | Protein kinase C as a target for the treatment of respiratory syncytial virus | Apr 2, 2009 | Abandoned |
Array
(
[id] => 8876033
[patent_doc_number] => 08470999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'Oligonucleotides for treating inflammation and neoplastic cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 12/992885
[patent_app_country] => US
[patent_app_date] => 2009-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29693
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12992885
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992885 | Oligonucleotides for treating inflammation and neoplastic cell proliferation | Mar 30, 2009 | Issued |
Array
(
[id] => 7574158
[patent_doc_number] => 20110269814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => '2\'-F MODIFIED RNA INTERFERENCE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/935083
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 87518
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269814.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935083
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935083 | 2'-F MODIFIED RNA INTERFERENCE AGENTS | Mar 25, 2009 | Abandoned |
Array
(
[id] => 8772422
[patent_doc_number] => 08426378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-23
[patent_title] => 'Oligomeric compounds comprising tricyclic nucelosides and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 12/922832
[patent_app_country] => US
[patent_app_date] => 2009-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28535
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922832
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/922832 | Oligomeric compounds comprising tricyclic nucelosides and methods for their use | Mar 18, 2009 | Issued |
Array
(
[id] => 6196773
[patent_doc_number] => 20110028531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'NOVEL SIRNA COMPOUNDS FOR INHIBITING RTP801'
[patent_app_type] => utility
[patent_app_number] => 12/736230
[patent_app_country] => US
[patent_app_date] => 2009-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45757
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028531.pdf
[firstpage_image] =>[orig_patent_app_number] => 12736230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/736230 | NOVEL SIRNA COMPOUNDS FOR INHIBITING RTP801 | Mar 16, 2009 | Abandoned |
Array
(
[id] => 6630079
[patent_doc_number] => 20100004315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'Biodegradable Cross-Linked Branched Poly(Alkylene Imines)'
[patent_app_type] => utility
[patent_app_number] => 12/404989
[patent_app_country] => US
[patent_app_date] => 2009-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12035
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20100004315.pdf
[firstpage_image] =>[orig_patent_app_number] => 12404989
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/404989 | Biodegradable Cross-Linked Branched Poly(Alkylene Imines) | Mar 15, 2009 | Abandoned |
Array
(
[id] => 6026489
[patent_doc_number] => 20110054009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/919888
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 36536
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20110054009.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919888
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919888 | MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders | Feb 26, 2009 | Abandoned |
Array
(
[id] => 6024176
[patent_doc_number] => 20110052502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/919904
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 187
[patent_figures_cnt] => 187
[patent_no_of_words] => 24254
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052502.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919904
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919904 | MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof | Feb 26, 2009 | Abandoned |
Array
(
[id] => 6001692
[patent_doc_number] => 20110117567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Micro-RNA Associated With Rheumatoid Arthritis'
[patent_app_type] => utility
[patent_app_number] => 13/001812
[patent_app_country] => US
[patent_app_date] => 2009-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6102
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117567.pdf
[firstpage_image] =>[orig_patent_app_number] => 13001812
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/001812 | Micro-RNA Associated With Rheumatoid Arthritis | Feb 22, 2009 | Abandoned |
Array
(
[id] => 6538586
[patent_doc_number] => 20100204299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'C-CBL AND ANTAGONISTS THEREOF FOR THE TREATMENT AND DIAGNOSIS OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/369309
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11930
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204299.pdf
[firstpage_image] =>[orig_patent_app_number] => 12369309
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/369309 | C-CBL AND ANTAGONISTS THEREOF FOR THE TREATMENT AND DIAGNOSIS OF CANCER | Feb 10, 2009 | Abandoned |
Array
(
[id] => 5503013
[patent_doc_number] => 20090163701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'siRNA targeting tumor necrosis factor receptor superfamily member 1A'
[patent_app_type] => utility
[patent_app_number] => 12/322980
[patent_app_country] => US
[patent_app_date] => 2009-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 28671
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163701.pdf
[firstpage_image] =>[orig_patent_app_number] => 12322980
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/322980 | siRNA targeting tumor necrosis factor receptor superfamily member 1A | Feb 9, 2009 | Abandoned |
Array
(
[id] => 6047606
[patent_doc_number] => 20110207197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'METHOD TO INHIBIT RIBONUCLEASE DICER, RIBONUCLEASE DICER INHIBITOR, AND USE OF RNA APTAMERS AS RIBONUCLEASE DICER INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/867471
[patent_app_country] => US
[patent_app_date] => 2009-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7675
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867471
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867471 | METHOD TO INHIBIT RIBONUCLEASE DICER, RIBONUCLEASE DICER INHIBITOR, AND USE OF RNA APTAMERS AS RIBONUCLEASE DICER INHIBITORS | Feb 8, 2009 | Abandoned |
Array
(
[id] => 6003442
[patent_doc_number] => 20110118340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'DELIVERY OF RNAI CONSTRUCTS TO OLIGODENDROCYTES'
[patent_app_type] => utility
[patent_app_number] => 12/866444
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 39628
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118340.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866444
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866444 | DELIVERY OF RNAI CONSTRUCTS TO OLIGODENDROCYTES | Feb 5, 2009 | Abandoned |
Array
(
[id] => 16650206
[patent_doc_number] => 10927371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Cationic siRNAs, synthesis and use for RNA interference
[patent_app_type] => utility
[patent_app_number] => 12/735595
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 6
[patent_no_of_words] => 4511
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12735595
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735595 | Cationic siRNAs, synthesis and use for RNA interference | Jan 29, 2009 | Issued |
Array
(
[id] => 6580459
[patent_doc_number] => 20100291036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/812735
[patent_app_country] => US
[patent_app_date] => 2009-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15993
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291036.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812735
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812735 | COMPOSITIONS AND METHODS FOR MODULATING VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION | Jan 24, 2009 | Abandoned |
Array
(
[id] => 6254964
[patent_doc_number] => 20100029003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'System and methods for identifying miRNA targets and for altering miRNA and target expression'
[patent_app_type] => utility
[patent_app_number] => 12/321489
[patent_app_country] => US
[patent_app_date] => 2009-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 58593
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12321489
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/321489 | System and methods for identifying miRNA targets and for altering miRNA and target expression | Jan 20, 2009 | Abandoned |
Array
(
[id] => 5354695
[patent_doc_number] => 20090186039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'NOVEL USE OF GRP 94 IN VIRUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 12/355747
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9367
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186039.pdf
[firstpage_image] =>[orig_patent_app_number] => 12355747
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/355747 | NOVEL USE OF GRP 94 IN VIRUS INFECTION | Jan 15, 2009 | Abandoned |
Array
(
[id] => 5354715
[patent_doc_number] => 20090186059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'DEVICES AND METHODS FOR ELUTION OF NUCLEIC ACID DELIVERY COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 12/353792
[patent_app_country] => US
[patent_app_date] => 2009-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11352
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186059.pdf
[firstpage_image] =>[orig_patent_app_number] => 12353792
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/353792 | DEVICES AND METHODS FOR ELUTION OF NUCLEIC ACID DELIVERY COMPLEXES | Jan 13, 2009 | Abandoned |